USFDA completes inspection at facility of Granules India’s arm

23 Jul 2022 Evaluate
The USFDA has completed an inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of Granules India located in Chantilly, Virginia, the USA on July 22, 2022 with six observations. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

579.40 19.90 (3.56%)
10-Mar-2026 10:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1816.45
Dr. Reddys Lab 1314.50
Cipla 1322.40
Zydus Lifesciences 916.60
Lupin 2342.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×